Explore News
-
FDA Blocks Melanoma Treatment for 33% Survival Gain
The FDA’s rejection of a promising melanoma therapy has sparked outcry from oncologists and patient…
-
Why the FDA Just Ousted a Controversial Drug Chief
Dr. Tracy Beth Hoeg’s departure marks a pivotal shift in the FDA’s drug approval leadership…
